Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Vera Bradley Announces Fiscal First Quarter 2018 Results
May 31, 2017 12:08 pm UTC| Business
First quarter net revenues totaled $96.1 million, in line with guidance First quarter net loss on a GAAP basis totaled ($4.0) million, or ($0.11) per diluted share; first quarter net loss on a non-GAAP basis (excluding...
Vera Bradley Announces Fiscal First Quarter 2018 Results
May 31, 2017 12:08 pm UTC| Business
First quarter net revenues totaled $96.1 million, in line with guidance First quarter net loss on a GAAP basis totaled ($4.0) million, or ($0.11) per diluted share; first quarter net loss on a non-GAAP basis (excluding...
Vera Bradley Announces Fiscal First Quarter 2018 Results
May 31, 2017 12:08 pm UTC| Business
First quarter net revenues totaled $96.1 million, in line with guidance First quarter net loss on a GAAP basis totaled ($4.0) million, or ($0.11) per diluted share; first quarter net loss on a non-GAAP basis (excluding...
India–US Trade Pact 2026: A New Highway to a USD 500 Billion Partnership